Gapping down
In reaction to disappointing earnings/guidance: ALXA -21.4%, (believes sufficient capital resources until the end of April 2016), CONN -13.7%, SID-8.3%, SNX -8%, ICON -2.9%, CCM -1.9%
M&A news: AFFX -0.9% (Origin withdraws $17.00 per share all-cash offer due to 'unreasonable demands and timeline')
Select metals/mining stocks trading lower: RIO -3.3%, BHP -3.3%, FCX-3%, AA -1.2%
Select oil/gas related names showing early weakness: SDRL -7.4%, RIG-6.1%, CHK -4.3%, WLL -3.5%, PBR -2.4%, RDS.A -1.2%
Other news: GEVO -29.3% (prices $3.5 million public offering of common stock at $0.35/share and warrants), TROV -18.8% (terminates the employment of CEO and CFO for cause; filed a complaint against each for breach of fiduciary duty), BPMX -18.4% (to offer and sell common stock and warrants in an underwritten public offering ), PRKR -17.2% (Parkervision announces that the US Supreme Court has declined its pettition requesting a review of the decision of the US Court of Appeals b/t the co and Qualcomm), PBYI -16.2% ( plans to submit NDA for the approval of neratinib for the treatment of extended adjuvant breast cancer in mid-2016 after meetings with FDA), TERP -15.5% (in symp with SUNE), MDVN -6.2% (Senate and House members send letter to the Department of Health and Human Services and the NIH to step in to lower the cost of a prostate cancer drug Xtandi)
Analyst comments: SWKS -2.5% (downgraded to Neutral from Buy at Citigroup), CMG -2.1% (downgraded to Underperform from Neutral at Wedbush), MU -1.7% (downgraded to Underperform at Needham), BWA-1.5% (downgraded to Neutral from Buy at Citigroup), LNKD -1.6% (downgraded to Equal Weight from Overweight), EBAY -1.5% (downgraded to Underweight at Barclays)
In reaction to disappointing earnings/guidance: ALXA -21.4%, (believes sufficient capital resources until the end of April 2016), CONN -13.7%, SID-8.3%, SNX -8%, ICON -2.9%, CCM -1.9%
M&A news: AFFX -0.9% (Origin withdraws $17.00 per share all-cash offer due to 'unreasonable demands and timeline')
Select metals/mining stocks trading lower: RIO -3.3%, BHP -3.3%, FCX-3%, AA -1.2%
Select oil/gas related names showing early weakness: SDRL -7.4%, RIG-6.1%, CHK -4.3%, WLL -3.5%, PBR -2.4%, RDS.A -1.2%
Other news: GEVO -29.3% (prices $3.5 million public offering of common stock at $0.35/share and warrants), TROV -18.8% (terminates the employment of CEO and CFO for cause; filed a complaint against each for breach of fiduciary duty), BPMX -18.4% (to offer and sell common stock and warrants in an underwritten public offering ), PRKR -17.2% (Parkervision announces that the US Supreme Court has declined its pettition requesting a review of the decision of the US Court of Appeals b/t the co and Qualcomm), PBYI -16.2% ( plans to submit NDA for the approval of neratinib for the treatment of extended adjuvant breast cancer in mid-2016 after meetings with FDA), TERP -15.5% (in symp with SUNE), MDVN -6.2% (Senate and House members send letter to the Department of Health and Human Services and the NIH to step in to lower the cost of a prostate cancer drug Xtandi)
Analyst comments: SWKS -2.5% (downgraded to Neutral from Buy at Citigroup), CMG -2.1% (downgraded to Underperform from Neutral at Wedbush), MU -1.7% (downgraded to Underperform at Needham), BWA-1.5% (downgraded to Neutral from Buy at Citigroup), LNKD -1.6% (downgraded to Equal Weight from Overweight), EBAY -1.5% (downgraded to Underweight at Barclays)